Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,376,490
  • Shares Outstanding, K 314,629
  • Annual Sales, $ 3,019 M
  • Annual Income, $ 72,060 K
  • EBIT $ 392 M
  • EBITDA $ 638 M
  • 60-Month Beta 1.32
  • Price/Sales 1.36
  • Price/Cash Flow 8.38
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 75.42% (-11.49%)
  • Historical Volatility 41.94%
  • IV Percentile 40%
  • IV Rank 42.05%
  • IV High 175.93% on 03/30/26
  • IV Low 2.47% on 09/09/25
  • Expected Move (DTE 24) 1.37 (10.32%)
  • Put/Call Vol Ratio 0.46
  • Today's Volume 19
  • Volume Avg (30-Day) 74
  • Put/Call OI Ratio 1.12
  • Today's Open Interest 2,427
  • Open Int (30-Day) 2,428
  • Expected Range 11.89 to 14.63

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.15
  • Number of Estimates 1
  • High Estimate $0.15
  • Low Estimate $0.15
  • Prior Year $0.19
  • Growth Rate Est. (year over year) -21.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.71 +13.24%
on 03/24/26
13.92 -4.74%
on 04/20/26
+1.43 (+12.09%)
since 03/20/26
3-Month
11.71 +13.24%
on 03/24/26
15.42 -14.01%
on 02/17/26
-0.07 (-0.53%)
since 01/20/26
52-Week
7.02 +88.89%
on 05/23/25
15.42 -14.01%
on 02/17/26
+5.90 (+80.16%)
since 04/17/25

Most Recent Stories

More News
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

Phase 4 ELEVATE-PD interim data (n=111) demonstrated clinically meaningful, consistent benefits of CREXONT across all prior treatment groups Demonstrated substantial increases in daily “Good On” time,...

AMRX : 13.26 (-4.67%)
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know

Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know

PACB : 1.7400 (+2.96%)
BRKR : 41.10 (+0.98%)
AMPH : 22.92 (+0.17%)
XRAY : 12.79 (+2.24%)
AMRX : 13.26 (-4.67%)
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.

Launch of albuterol sulfate inhalation aerosol and beclomethasone dipropionate HFA inhalation aerosol BRIDGEWATER, N.J., April 14, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal”...

AMRX : 13.26 (-4.67%)
2 Cash-Producing Stocks to Research Further and 1 We Brush Off

2 Cash-Producing Stocks to Research Further and 1 We Brush Off

VEEV : 168.84 (+0.53%)
AMRX : 13.26 (-4.67%)
PM : 157.55 (-0.15%)
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%

BRIDGEWATER, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the launch of bimatoprost ophthalmic solution 0.01% (2.5 mL, 5 mL...

AMRX : 13.26 (-4.67%)
3 of Wall Street’s Favorite Stocks We Steer Clear Of

3 of Wall Street’s Favorite Stocks We Steer Clear Of

WW : 10.00 (-8.93%)
RRX : 207.96 (+1.25%)
AMRX : 13.26 (-4.67%)
Amneal to Report First Quarter 2026 Results on May 1, 2026

BRIDGEWATER, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced that the Company will release its first quarter...

AMRX : 13.26 (-4.67%)
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month

BRIDGEWATER, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced donations totaling $2 million to multiple patient...

AMRX : 13.26 (-4.67%)
3 Small-Cap Stocks Walking a Fine Line

3 Small-Cap Stocks Walking a Fine Line

NSIT : 76.46 (+0.04%)
RPD : 5.83 (+2.64%)
AMRX : 13.26 (-4.67%)
Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment

Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment

AMRX : 13.26 (-4.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 14.57
2nd Resistance Point 14.25
1st Resistance Point 13.75
Last Price 13.26
1st Support Level 12.93
2nd Support Level 12.61
3rd Support Level 12.11

See More

52-Week High 15.42
Last Price 13.26
Fibonacci 61.8% 12.21
Fibonacci 50% 11.22
Fibonacci 38.2% 10.23
52-Week Low 7.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.